Literature DB >> 3261521

MR of cranial and spinal meningeal carcinomatosis: comparison with CT and myelography.

G Krol1, G Sze, M Malkin, R Walker.   

Abstract

Thirty-nine patients with histologically proved primary neoplasms, focal neurologic deficits, and positive CSF cytology were evaluated by enhanced cranial CT and MR, or complete myelography and MR of the spine. Intracranial abnormalities were noted on CT in 56% of cases and included abnormal enhancement of subarachnoid space and ventricular walls, ventricular dilatation, obliteration of cortical sulci, and enhancing nodules within the subarachnoid cisterns and lumen of the lateral ventricles. Although the degree of ventricular enlargement and intraventricular tumor deposits were equally well seen on CT and MR, involvement of ventricular walls, tentorium, subarachnoid cisterns, or subarachnoid space interpreted as abnormal enhancement on CT was not readily appreciated on routine T1- and T2-weighted spin-echo sequences. Forty-four percent of CT and 65% of MR studies were interpreted as normal. There was high correlation of myelographic findings with clinical diagnosis, and no false-negative myelograms. Nodular filling defects within the subarachnoid space, thickening and crowding of roots of the cauda equina, irregularity of individual roots, and scalloping of the subarachnoid membranes were demonstrated. MR was rather insensitive in detecting these changes, revealing a definite abnormality of the subarachnoid space in 27% of patients with positive myelograms. False-negative interpretation of MR of the spine was made in 44% of cases.

Entities:  

Mesh:

Year:  1988        PMID: 3261521     DOI: 10.2214/ajr.151.3.583

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  14 in total

Review 1.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

Review 2.  Myelopathy.

Authors:  D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-05       Impact factor: 3.825

Review 3.  In situ hybridization: a possible diagnostic aid in leptomeningeal metastasis.

Authors:  R J van Oostenbrugge; A H Hopman; F C Ramaekers; A Twijnstra
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

Review 4.  Leptomeningeal metastases from solid malignancy: a review.

Authors:  Sophie Taillibert; Florence Laigle-Donadey; Catherine Chodkiewicz; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

5.  Unusual enhancement on gadolinium-enhanced MRI in a case of primary cerebellar lymphoma.

Authors:  R K Gupta; S Gupta; P Mittal; R Pandey; A Kohli; R B Gujral
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Detection of dural involvement by magnetic resonance imaging in adult patients with acute leukemias--preliminary experience.

Authors:  C Y Wu; J L Tang; Y C Chen; H F Tien; M T Lin; M Yao; H M Liu
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

7.  Myelography, CT and MRI in leukaemic infiltration of the lumbar theca.

Authors:  W C Shen; S K Lee; Y J Ho; K R Lee
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

8.  Correlation of MRI and clinical features in meningeal carcinomatosis.

Authors:  M Watanabe; R Tanaka; N Takeda
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

9.  MRI of subarachnoid dissemination of medulloblastoma.

Authors:  M Kochi; Y Mihara; A Takada; C Yatomi; M Morioka; S Yamashiro; S Yano; J Kuratsu; S Uemura; Y Ushio
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

10.  Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI.

Authors:  G Rodesch; P Van Bogaert; N Mavroudakis; P M Parizel; J J Martin; C Segebarth; M Van Vyve; D Baleriaux; J Hildebrand
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.